S&P 500 7,459.94 â–ŧ 73.83 (-0.98%) DOW 52,169.10 â–ŧ 383.87 (-0.73%) NASDAQ 25,535.42 â–ŧ 346.53 (-1.34%) US Markets Closed â€ĸ 08:58 AM ET

PHG

Koninklijke Philips N.V.

Price Chart
Latest Quote

$26.98

-0.31 (-1.14%)
Current Price
Previous Close $27.29
Open $27.19
Day High $27.24
Day Low $26.89
Volume 320,688
Fetched: 2026-07-17T16:28:13
Stock Information
Note: Financial values converted from EUR to USD
Quarterly Dividend / Yield $1.01 / 3.76%
Shares Outstanding 971.98M
Quarterly Dividend Yield 3.76%
Quarterly Dividend $1.01
Total Debt $9.27B
Cash Equivalents $2.97B
Revenue $20.19B
Net Income $1.11B
Sector Healthcare
Industry Medical Devices
Market Cap $26.19B
P/E Ratio 23.64
EPS (TTM) $1.14
Exchange NYQ
🌐 Visit Website
📊 Comprehensive Analysis
Company Data
Enterprise Value$31.19B
Sales$20.19B
Income$1.11B
Book/sh$13.72
Cash/sh$2.67
Employees64K
Financial Ratios
Quick Ratio0.79
Current Ratio1.32
Debt/Eq70.91
EPS Growth TTM98.70%
Returns & Margins
ROA3.48%
ROE8.36%
Gross Margin45.20%
Operating Margin6.17%
Profit Margin5.50%
Ownership
Institutional Ownership5.54%
Insider & Institutional transactions data not available
Valuation Ratios
Forward P/E13.33
PEG0.91
P/S1.48
P/B1.96
Analyst Data
Recommendationhold
Target Price$33.26
Technical Indicators
SMA20$27.21
SMA50$26.59
SMA200$27.11
RSI48.55
ATR0.5571
Shares Float951.21M
Short Ratio1.45
Volatility0.92
Rel Volume0.72
Performance History
Week-1.64%
Month+0.56%
Quarter-2.20%
6 Months-6.98%
YTD+3.44%
Year+14.85%
3 Years+29.73%
5 Years-34.57%
10 Years+28.61%
Stock Score: ⭐ Premium
Based on debt, profitability, growth, and cash flow metrics
⭐ Premium Feature

Sign up for free to view detailed scoring breakdown — premium is free during our trial period!

Recent Price History
Date Close Volume
2026-07-17 $26.95 691,600
2026-07-16 $27.29 889,800
2026-07-15 $27.02 1,150,400
2026-07-14 $26.06 1,459,100
2026-07-13 $27.34 655,700
2026-07-10 $27.40 641,600
2026-07-09 $27.26 1,068,000
2026-07-08 $27.58 754,000
2026-07-07 $28.23 839,900
2026-07-06 $28.16 1,030,900
2026-07-02 $27.74 930,300
2026-07-01 $27.20 707,800
2026-06-30 $27.19 1,091,800
2026-06-29 $27.21 828,900
2026-06-26 $27.10 908,900
2026-06-25 $27.29 848,400
2026-06-24 $26.73 1,190,400
2026-06-23 $26.61 748,200
2026-06-22 $26.98 1,200,900
2026-06-18 $26.78 1,496,700
About Koninklijke Philips N.V.

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. The company provides diagnostic imaging solutions, includes ultrasound business unit, magnetic resonance imaging, computed tomography, and diagnostic x-ray; Image Guided Therapy, including image guided therapy systems and image guided therapy devices. It also offers monitoring, enterprise informatics, and sleep and respiratory care, as well as personal health. Koninklijke Philips N.V. has strategic alliance with WellSpan Health to advanced imaging and diagnostics technology products and platforms. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.

Period:
Loading...
Income Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Revenue
Reconciled Cost Of Revenue $11,187,915,419 $11,728,084,822 $12,269,398,651 $12,168,689,101
Cost Of Revenue $11,187,915,419 $11,728,084,822 $12,269,398,651 $12,168,689,101
Total Revenue $20,409,705,768 $20,623,713,561 $20,793,088,712 $20,401,694,781
Operating Revenue $19,982,834,609 $20,218,586,509 $20,346,762,299 $19,954,223,941
Expenses
Interest Expense $336,461,450 $385,671,798 $350,194,570 $279,240,115
Total Expenses $18,751,431,480 $20,036,622,664 $20,985,352,398 $20,604,258,307
Other Income Expense $-57,221,335 $-152,208,751 $-105,287,256 $-1,524,376,364
Net Non Operating Interest Income Expense $-247,196,167 $-294,117,662 $-304,417,502 $-255,207,154
Total Other Finance Cost $5,722,134 $-1,144,427 $6,866,560 $4,577,707
Interest Expense Non Operating $336,461,450 $385,671,798 $350,194,570 $279,240,115
Operating Expense $7,563,516,060 $8,308,537,842 $8,715,953,747 $8,435,569,206
Other Operating Expenses $-69,810,029 $509,269,881 $679,789,460 $-13,733,120
Selling And Marketing Expense $4,969,100,731 $5,133,898,176 $5,177,386,391 $5,288,395,781
General And Administrative Expense $718,699,968 $666,056,339 $695,811,434 $767,910,316
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $1,028,839,603 $-965,896,135 $-521,858,575 $-1,855,115,681
Net Interest Income $-247,196,167 $-294,117,662 $-304,417,502 $-255,207,154
Interest Income $94,987,416 $90,409,709 $52,643,628 $28,610,667
Normalized Income $1,064,687,625 $-958,253,653 $-527,557,820 $-431,963,858
Net Income From Continuing And Discontinued Operation $1,024,261,896 $-803,387,543 $-533,302,842 $-1,840,238,134
Total Operating Income As Reported $1,629,663,621 $605,401,724 $-131,609,070 $-1,749,828,424
Net Income Common Stockholders $1,024,261,896 $-803,387,543 $-533,302,842 $-1,840,238,134
Net Income $1,024,261,896 $-803,387,543 $-533,302,842 $-1,840,238,134
Net Income Including Noncontrolling Interests $1,026,550,750 $-798,809,837 $-529,869,562 $-1,836,804,853
Net Income Discontinuous Operations $-4,577,707 $162,508,591 $-11,444,267 $14,877,547
Net Income Continuous Operations $1,031,128,457 $-961,318,428 $-519,569,722 $-1,851,682,401
Pretax Income $1,352,712,359 $140,764,484 $-601,968,444 $-1,981,002,618
Special Income Charges $-27,466,241 $18,310,827 $60,654,615 $-1,546,120,472
Earnings From Equity Interest $-10,299,840 $-141,908,911 $-112,153,817 $-2,288,853
Interest Income Non Operating $94,987,416 $90,409,709 $52,643,628 $28,610,667
Operating Income $1,658,274,288 $587,090,897 $-192,263,686 $-202,563,526
Gross Profit $9,221,790,349 $8,895,628,739 $8,523,690,062 $8,233,005,680
Per Share
Diluted EPS $1.08 $-0.86 $-0.56 $-1.93
Basic EPS $1.08 $-0.86 $-0.56 $-1.93
Other
Tax Effect Of Unusual Items $-11,073,473 $-2,657,359 $1,167,315 $-98,935,688
Tax Rate For Calcs $0 $0 $0 $0
Normalized EBITDA (Bullshit earnings) $3,022,430,915 $2,126,344,809 $1,184,481,634 $1,653,696,581
Total Unusual Items $-46,921,495 $-10,299,840 $6,866,560 $-1,522,087,511
Total Unusual Items Excluding Goodwill $-46,921,495 $-10,299,840 $6,866,560 $-1,522,087,511
Reconciled Depreciation $1,286,335,611 $1,589,608,686 $1,443,122,069 $1,833,371,573
EBITDA (Bullshit earnings) $2,975,509,420 $2,116,044,968 $1,191,348,195 $131,609,070
EBIT $1,689,173,809 $526,436,282 $-251,773,874 $-1,701,762,503
Diluted Average Shares $1,101,514,132 $1,068,174,693 $1,085,815,746 $1,090,017,720
Basic Average Shares $1,085,190,030 $1,068,174,693 $1,085,815,746 $1,090,017,720
Diluted NI Availto Com Stockholders $1,024,261,896 $-803,387,543 $-533,302,842 $-1,840,238,134
Minority Interests $-1,144,427 $-3,433,280 $-2,288,853 $-3,433,280
Tax Provision $322,728,329 $1,102,082,912 $-83,543,149 $-129,320,217
Gain On Sale Of Ppe $1,144,427 $3,433,280 $12,588,694 $2,288,853
Gain On Sale Of Business $-28,610,667 $14,877,547 $57,221,335 $4,577,707
Impairment Of Capital Assets $0 $0 $9,155,414 $1,552,987,032
Gain On Sale Of Security $-19,455,254 $-28,610,667 $-53,788,055 $24,032,961
Research And Development $1,945,525,390 $1,999,313,445 $2,162,966,463 $2,392,996,230
Selling General And Administration $5,687,800,699 $5,799,954,516 $5,873,197,824 $6,056,306,096
Other Gand A $718,699,968 $666,056,339 $695,811,434 $767,910,316
Fetched: 2026-07-17
Balance Sheet (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Assets
Net Tangible Assets $-1,010,528,776 $-1,556,420,312 $-1,190,203,768 $-589,379,750
Total Assets $30,835,433,005 $33,160,908,059 $33,653,011,540 $35,120,166,570
Total Non Current Assets $19,468,987,020 $21,692,608,098 $22,277,410,142 $23,379,493,054
Other Non Current Assets $136,186,777 $140,764,484 $104,142,830 $112,153,817
Non Current Deferred Assets $2,029,068,539 $2,192,721,557 $3,006,408,941 $2,802,700,988
Non Current Deferred Taxes Assets $2,029,068,539 $2,192,721,557 $3,006,408,941 $2,802,700,988
Non Current Accounts Receivable $240,329,607 $238,040,754 $220,874,353 $319,295,049
Investmentin Financial Assets $805,676,397 $723,277,674 $708,400,127 $755,321,622
Financial Assets Designatedas Fair Value Through Profitor Loss Total $434,882,146 $329,594,890 $325,017,183 $368,505,397
Goodwill And Other Intangible Assets $13,550,012,128 $15,296,407,272 $14,955,368,116 $15,751,889,099
Other Intangible Assets $2,940,032,192 $3,413,824,846 $3,651,865,600 $4,035,248,544
Current Assets $11,366,445,984 $11,469,444,387 $11,375,601,398 $11,740,673,515
Other Current Assets $-5,722,134 $1,144,427 $5,722,134 -
Hedging Assets Current $92,698,563 $78,965,442 $51,499,201 $140,764,484
Assets Held For Sale Current $76,676,589 $0 $90,409,709 $88,120,856
Prepaid Assets $205,996,806 $272,373,555 $225,452,060 $199,130,246
Inventory $3,284,504,629 $3,659,876,587 $3,995,193,610 $4,633,783,708
Receivables $4,514,763,332 $4,709,315,870 $4,864,957,902 $5,325,017,435
Other Receivables $603,112,871 $552,758,096 $534,447,269 $622,568,125
Taxes Receivable $68,665,602 $107,576,110 $251,773,874 $254,062,727
Accounts Receivable $3,821,240,751 $4,020,370,997 $4,058,137,078 $4,385,443,114
Allowance For Doubtful Accounts Receivable $-220,874,353 $-280,384,542 $-280,384,542 $-258,640,434
Gross Accounts Receivable $4,042,115,104 $4,300,755,539 $4,338,521,620 $4,644,083,549
Cash Cash Equivalents And Short Term Investments $3,197,528,200 $2,747,768,507 $2,142,366,782 $1,353,856,786
Cash And Cash Equivalents $3,197,528,200 $2,747,768,507 $2,138,933,502 $1,341,268,092
Cash Equivalents $2,387,274,096 $2,227,054,358 $1,601,052,953 $551,613,669
Cash Financial $810,254,104 $520,714,148 $537,880,549 $789,654,423
Financial Assets - $9,155,414 $3,433,280 $4,577,707
Debt
Net Debt $4,638,361,415 $4,597,162,054 $4,977,111,718 $5,822,843,050
Total Debt $8,939,116,954 $8,572,900,410 $8,346,303,923 $8,402,380,831
Long Term Debt And Capital Lease Obligation $7,794,690,254 $8,065,919,382 $7,964,065,405 $8,030,442,154
Long Term Debt $6,928,359,242 $7,088,578,980 $6,975,280,736 $7,055,390,605
Current Debt And Capital Lease Obligation $1,144,426,700 $506,981,028 $382,238,518 $371,938,677
Current Debt $907,530,373 $256,351,581 $140,764,484 $108,720,536
Other Current Borrowings $848,020,185 $151,064,324 $1,144,427 $6,866,560
Liabilities
Total Liabilities Net Minority Interest $18,259,327,998 $19,378,577,311 $19,850,081,112 $19,918,746,714
Total Non Current Liabilities Net Minority Interest $9,663,539,055 $10,058,366,266 $10,367,361,475 $10,838,865,276
Other Non Current Liabilities $50,354,775 $191,119,259 $64,087,895 $68,665,602
Derivative Product Liabilities $140,764,484 $75,532,162 $90,409,709 $292,973,235
Non Current Deferred Liabilities $630,579,112 $585,946,470 $617,990,418 $693,522,580
Non Current Deferred Taxes Liabilities $106,431,683 $92,698,563 $81,254,296 $104,142,830
Current Liabilities $8,595,788,944 $9,320,211,045 $9,482,719,636 $9,079,881,438
Other Current Liabilities $367,360,971 $241,474,034 $535,591,696 $1,067,750,111
Current Deferred Liabilities $1,705,195,783 $1,944,380,963 $2,070,267,900 $1,940,947,683
Payables And Accrued Expenses $4,563,973,680 $4,364,843,434 $4,820,325,260 $4,534,218,585
Interest Payable $108,720,536 $94,987,416 $86,976,429 $81,254,296
Payables $2,576,104,502 $2,325,475,054 $2,462,806,258 $2,429,617,884
Other Payable $19,455,254 $18,310,827 $13,733,120 $9,155,414
Total Tax Payable $351,338,997 $212,863,366 $242,618,460 $177,386,138
Income Tax Payable $199,130,246 $81,254,296 $94,987,416 $45,777,068
Accounts Payable $2,205,310,251 $2,094,300,861 $2,193,865,984 $2,252,231,746
Tradeand Other Payables Non Current - $136,186,777 $446,326,413 $497,825,614
Dividends Payable - $0 $12,588,694 $0
Equity
Common Stock Equity $12,539,483,352 $13,739,986,960 $13,765,164,348 $15,162,509,348
Total Equity Gross Minority Interest $12,576,105,006 $13,782,330,748 $13,802,930,429 $15,201,419,856
Stockholders Equity $12,539,483,352 $13,739,986,960 $13,765,164,348 $15,162,509,348
Other Equity Interest $-18,310,827 $-115,587,097 $-1,144,427 $1,144,427
Gains Losses Not Affecting Retained Earnings $333,028,170 $2,203,021,398 $1,005,951,069 $1,702,906,930
Other Equity Adjustments $-64,087,895 $-101,853,976 $6,866,560 $-2,288,853
Retained Earnings $4,091,325,452 $4,177,157,455 $6,182,193,033 $7,818,723,214
Long Term Equity Investment $169,375,152 $294,117,662 $436,026,573 $614,557,138
Other
Treasury Shares Number $13,311,054 $17,086,645 $8,418,208 $8,966,074
Ordinary Shares Number $1,088,680,455 $1,058,605,082 $1,072,753,334 $1,089,850,223
Share Issued $1,101,991,509 $1,075,691,727 $1,081,171,542 $1,089,850,223
Tangible Book Value $-1,010,528,776 $-1,556,420,312 $-1,190,203,768 $-589,379,750
Invested Capital $20,375,372,967 $21,084,917,521 $20,881,209,568 $22,326,620,490
Working Capital $2,770,657,041 $2,149,233,343 $1,892,881,762 $2,660,792,078
Capital Lease Obligations $1,103,227,339 $1,227,969,849 $1,230,258,702 $1,238,269,689
Total Capitalization $19,467,842,594 $20,828,565,940 $20,740,445,084 $22,217,899,954
Minority Interest $36,621,654 $42,343,788 $37,766,081 $38,910,508
Foreign Currency Translation Adjustments $397,116,065 $2,304,875,374 $1,445,410,922 $2,135,500,222
Treasury Stock $341,039,157 $470,359,374 $299,839,795 $314,717,342
Additional Paid In Capital $8,253,605,360 $7,730,602,358 $6,668,574,381 $5,750,744,168
Capital Stock $220,874,353 $215,152,220 $209,430,086 $203,707,953
Common Stock $220,874,353 $215,152,220 $209,430,086 $203,707,953
Non Current Deferred Revenue $524,147,429 $493,247,908 $536,736,122 $589,379,750
Long Term Capital Lease Obligation $866,331,012 $977,340,402 $988,784,669 $975,051,548
Long Term Provisions $1,047,150,430 $1,139,848,993 $1,184,481,634 $1,255,436,090
Current Deferred Revenue $1,705,195,783 $1,944,380,963 $2,070,267,900 $1,940,947,683
Current Capital Lease Obligation $236,896,327 $250,629,447 $241,474,034 $263,218,141
Line Of Credit $59,510,188 $105,287,256 $139,620,057 $101,853,976
Current Provisions $814,831,810 $2,262,531,586 $1,674,296,262 $1,165,026,381
Current Accrued Expenses $1,987,869,178 $2,039,368,379 $2,357,519,002 $2,104,600,701
Investments And Advances $975,051,548 $1,017,395,336 $1,144,426,700 $1,369,878,760
Available For Sale Securities $370,794,251 $393,682,785 $383,382,944 $386,816,225
Investmentsin Associatesat Cost $169,375,152 $294,117,662 $436,026,573 $614,557,138
Goodwill $10,609,979,936 $11,882,582,426 $11,303,502,516 $11,716,640,555
Net PPE $2,538,338,421 $2,807,278,695 $2,842,755,923 $3,018,997,635
Accumulated Depreciation $-4,240,100,923 $-4,565,118,106 $-4,211,490,256 $-4,130,235,960
Gross PPE $6,778,439,344 $7,372,396,801 $7,054,246,179 $7,150,378,022
Leases $1,519,798,658 $1,673,151,835 $1,630,808,047 $1,562,142,445
Construction In Progress $313,572,916 $310,139,636 $313,572,916 $353,627,850
Other Properties $1,906,614,882 $2,023,346,406 $1,853,971,254 $1,899,748,322
Machinery Furniture Equipment $1,773,861,385 $2,048,523,793 $1,981,002,618 $2,035,935,099
Land And Improvements $1,264,591,504 $1,317,235,132 $1,274,891,344 $1,298,924,304
Properties $0 $0 $0 $0
Finished Goods $1,472,877,163 $1,646,830,021 $1,864,271,094 $2,128,633,662
Work In Process $466,926,094 $473,792,654 $631,723,538 $741,588,502
Raw Materials $1,344,701,372 $1,538,109,485 $1,498,054,550 $1,763,561,545
Duefrom Related Parties Current $21,744,107 $28,610,667 $20,599,681 $62,943,468
Other Inventories - $1,144,427 $1,144,427 -
Other Short Term Investments - $2,288,853 $3,433,280 $12,588,694
Unrealized Gain Loss - - $-446,326,413 $-430,304,439
Held To Maturity Securities - - - $61,799,042
Fetched: 2026-07-17
Cash Flow Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Free Cash Flow
Free Cash Flow $576,791,057 $1,021,973,043 $1,707,484,636 $-1,120,393,739
Operating Activities
Operating Cash Flow $1,341,268,092 $1,795,605,492 $2,444,495,431 $-197,985,819
Cash Flow From Continuing Operating Activities $1,338,979,239 $1,795,605,492 $2,443,351,004 $-197,985,819
Operating Gains Losses $36,621,654 $122,453,657 $41,199,361 $-3,433,280
Investing Activities
Capital Expenditure $-764,477,036 $-773,632,449 $-737,010,795 $-922,407,920
Investing Cash Flow $-843,442,478 $-655,756,499 $-727,855,381 $-1,701,762,503
Cash Flow From Continuing Investing Activities $-842,298,051 $-655,756,499 $-728,999,808 $-1,700,618,076
Net Other Investing Changes $-1,144,427 - $1,144,427 $-1,144,427
Capital Expenditure Reported $-608,835,004 $-638,590,099 $-627,145,832 $-802,243,117
Financing Activities
Repurchase Of Capital Stock $0 $-470,359,374 $-757,610,475 $-214,007,793
Issuance Of Capital Stock $14,877,547 $0 $0 $13,733,120
Financing Cash Flow $122,453,657 $-567,635,643 $-970,473,842 $572,213,350
Cash Flow From Continuing Financing Activities $122,453,657 $-568,780,070 $-970,473,842 $569,924,497
Net Other Financing Charges $-2,288,853 $-1,144,427 $-3,433,280 $-4,577,707
Cash Dividends Paid $-375,371,958 $-1,144,427 $-2,288,853 $-471,503,800
Common Stock Dividend Paid $-375,371,958 $-1,144,427 $-2,288,853 $-471,503,800
Net Common Stock Issuance $14,877,547 $-470,359,374 $-757,610,475 $-200,274,672
Common Stock Issuance $14,877,547 $0 $0 $13,733,120
Dividend Received Cfo $14,877,547 $9,155,414 $14,877,547 $13,733,120
Other
Repayment Of Debt $-696,955,860 $-873,197,572 $-862,897,732 $-1,684,596,102
Issuance Of Debt $1,209,659,022 $812,542,957 $622,568,125 $2,879,377,577
End Cash Position $3,197,528,200 $2,747,768,507 $2,138,933,502 $1,341,268,092
Beginning Cash Position $2,747,768,507 $2,138,933,502 $1,341,268,092 $2,635,614,690
Effect Of Exchange Rate Changes $-159,075,311 $51,499,201 $-90,409,709 $46,921,495
Changes In Cash $608,835,004 $557,335,803 $888,075,119 $-1,341,268,092
Cash Flow From Discontinued Operation $-11,444,267 $-14,877,547 $140,764,484 $-13,733,120
Common Stock Payments $0 $-470,359,374 $-757,610,475 $-214,007,793
Net Issuance Payments Of Debt $485,236,921 $-94,987,416 $-207,141,233 $1,248,569,530
Net Short Term Debt Issuance $-27,466,241 $-34,332,801 $33,188,374 $53,788,055
Net Long Term Debt Issuance $512,703,162 $-60,654,615 $-240,329,607 $1,194,781,475
Long Term Debt Payments $-696,955,860 $-873,197,572 $-862,897,732 $-1,684,596,102
Long Term Debt Issuance $1,209,659,022 $812,542,957 $622,568,125 $2,879,377,577
Net Investment Purchase And Sale $-59,510,188 $-32,043,948 $-102,998,403 $-125,886,937
Sale Of Investment $69,810,029 $108,720,536 $54,932,482 $89,265,283
Purchase Of Investment $-129,320,217 $-140,764,484 $-157,930,885 $-215,152,220
Net Business Purchase And Sale $-28,610,667 $135,042,351 $8,010,987 $-672,922,900
Purchase Of Business $-28,610,667 $-9,155,414 $-83,543,149 $-814,831,810
Net Intangibles Purchase And Sale $-155,642,031 $-135,042,351 $-109,864,963 $-120,164,803
Purchase Of Intangibles $-155,642,031 $-135,042,351 $-109,864,963 $-120,164,803
Net PPE Purchase And Sale $10,299,840 $14,877,547 $102,998,403 $20,599,681
Sale Of PPE $10,299,840 $14,877,547 $102,998,403 $20,599,681
Taxes Refund Paid $-243,762,887 $-197,985,819 $-173,952,858 $-381,094,091
Interest Received Cfo $94,987,416 $94,987,416 $60,654,615 $17,166,400
Interest Paid Cfo $-289,539,955 $-298,695,369 $-286,106,675 $-234,607,473
Change In Working Capital $-1,409,933,694 $-107,576,110 $1,446,555,349 $-1,309,224,145
Change In Other Working Capital $-1,390,478,440 $361,638,837 $482,948,067 $-227,740,913
Change In Other Current Liabilities $61,799,042 $-58,365,762 $-43,488,215 $-96,131,843
Change In Payables And Accrued Expense $111,009,390 $-667,200,766 $409,704,759 $59,510,188
Change In Payable $111,009,390 $-667,200,766 $409,704,759 $59,510,188
Change In Account Payable $111,009,390 $-667,200,766 $409,704,759 $59,510,188
Change In Inventory $-131,609,070 $263,218,141 $294,117,662 $-654,612,072
Change In Receivables $-60,654,615 $-6,866,560 $303,273,076 $-390,249,505
Changes In Account Receivables $-10,299,840 $-1,144,427 $341,039,157 $-391,393,931
Other Non Cash Items $336,461,450 $331,883,743 $387,960,651 $185,397,125
Stock Based Compensation $161,364,165 $109,864,963 $100,709,550 $108,720,536
Asset Impairment Charge $0 $0 $9,155,414 $1,552,987,032
Deferred Tax $322,728,329 $1,103,227,339 $-81,254,296 $-129,320,217
Deferred Income Tax $322,728,329 $1,103,227,339 $-81,254,296 $-129,320,217
Depreciation Amortization Depletion $1,286,335,611 $1,589,608,686 $1,443,122,069 $1,833,371,573
Depreciation And Amortization $1,286,335,611 $1,589,608,686 $1,443,122,069 $1,833,371,573
Amortization Cash Flow $597,390,737 $793,087,703 $654,612,072 $1,019,684,190
Amortization Of Intangibles $597,390,737 $793,087,703 $654,612,072 $1,019,684,190
Depreciation $688,944,873 $796,520,983 $788,509,996 $813,687,384
Earnings Losses From Equity Investments $10,299,840 $144,197,764 $122,453,657 $128,175,790
Net Income From Continuing Operations $1,031,128,457 $-961,318,428 $-518,425,295 $-1,851,682,401
Sale Of Business - $144,197,764 $91,554,136 $141,908,911
Fetched: 2026-07-17